<p><i><strong>Individuals with a high polygenic risk are likely to derive the most benefit from lifestyle change and/or therapeutic intervention</strong></i></p>

<p><i><strong>Innovative ELN and Streamlined Interface Enhances Collaboration, Workflow Management, and Integrates Seamlessly with TeselaGen's Platform</strong></i></p>

<p><i><strong>New Members Strengthen Board of Directors</strong></i></p>

<p><i><strong>RMTG is pleased to announce the opening of our newest clinic, located at the Hyatt Hotel in Jumeirah, UAE.</strong></i></p>

<ul><li><strong>The climate, improved technology, and professional management drive 3,000% growth in cultivated area over 10 years in Spain. High demand and sustained growth establish pistachios as a future investment in Europe and Spain.</strong></li></ul>

LIPID inCode tests patients to identify familial hypercholesterolemia and prevent cardiovascular disease

Pioneering Study Aims to Inspire Further Research into Food Sensitivity Testing

This represents a monumental advancement for the hemp industry — a comprehensive processing solution from biomass input to T-free crude and/or distillate. This pioneering breakthrough addresses the challenge of processing 'hot' oil with noncompliant THC content, seamlessly processing to a T-free end product. This capability is also indispensable for facilities aspiring to operate under pharmaceutical and Good Manufacturing Practice (GMP) standards.

"Nando", a leading Lithuanian-owned biotechnology company known for its groundbreaking work in developing microbiological products for agriculture, that helped to save up to 50M on fertilisers, announces a significant bolstering of its management team and an ambitious expansion of its biotechnological production line. This move is set to position "Nando" not just as a leader in Lithuania but as a formidable player on the international stage.

Preventive Cardiology Congress Athens 2024

US Study Publication in the American Journal of Preventive Cardiology

Limulus Amebocyte Lysate (LAL) Can Now Be Produced Without Harvesting the Blood of ~800,000 Horseshoe Crabs Each Year, Which Will Help Restore Their Natural Population

SingleTimeMicroneedles wins the Food, Nutrition, and Health Category.

New Location Positions CIL for Product Development and Future Growth

Baltimore-based biotechnology leader, Elixirgen Scientific, Inc., achieves ISO 9001:2015 Quality Management System certification, strengthening commitment to quality, excellence in biotechnology and drug discovery.

Health Advance Partners Agree to Equity Stake in SingleTimeMicroneedles at a $3.5 Million Valuation

SingleTimeMicroneedles to showcase STM Patch in the Food, Nutrition, and Health category

Von Rohr Brings Over 25 Years of Experience to Company

Hausman brings over 25 years of financial and operational expertise to the company.

ZAGENO Recognized as a Trailblazer in the ProcureTech100 2023 Awards for its Revolutionary Marketplace

Vibrant America Achieves Seven-Year Re-Accreditation Milestone from the College of American Pathologists (CAP)

Aronora is Revolutionizing Blood Clot Treatment with Groundbreaking Innovations

Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams.

Coronary Heart Disease (CHD) prevention nearly twice as effective when using CARDIO inCode
as method to target treatment

PA-based clinical technology provider assisTek has announced new features to its upcoming software release, including AI Integration, a Proprietary OS, SSO & Remote Provisioning, to add to its growing suite of eCOA & ePRO solutions.

A Leap Forward for Patients, a Promising Opportunity for Investors, and a Revolutionary Tool for Physicians

Updates to Tempo's Manufacturing Execution System and Connected Manufacturing Network Drive Greater Efficiency and Scalability

LCTG-001 on course to be the first FDA-approved biologic from human milk

In a clinical validation study published on Scientific Reports, UNITY RhD NIPT and Fetal antigen NIPT demonstrated 100% sensitivity, 100% specificity, 99.9% precision with 0.1% no-call rate across 3,921 NIPT assays.

LGM Pharma opts to engage with BioPharma Connections for business development services

HanchorBio Received IND Approval of HCB101 Multi-Regional Clinical Trial By Taiwan FDA

Australia-Based Cure Brain Cancer Foundation, Qatar Cancer Society, Initiate Discussion of Strategic Collaborative Partnership

ZAGENO Empowers Life Science Research with Unparalleled Efficiency and Cost Savings

Enhanced FDA reporting, full IQ/OQ package & incubator monitoring sensor round out Lab21 offerings